Benlysta® Belimumab 200 mg / mL Injection Prefilled Syringe 4 per Box

Name: Immunosuppressive Agent
Brand: Benlysta®

McKesson #

1184513

Manufacturer #

49401008847

Brand

Benlysta®

Manufacturer

Glaxo Specialty

Country of Origin

Unknown

Application

Immunosuppressive Agent

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Name

Belimumab

NDC Number

49401008847

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Quantity

4 per Box

Storage Requirements

Requires Refrigeration

Strength

200 mg / mL

Type

Subcutaneous

UNSPSC Code

51202403

BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of: adult patients with active lupus nephritis who are receiving standard therapy.
BENLYSTA (belimumab) injection is a clear to opalescent, and colorless to pale yellow solution for subcutaneous use. Each single-dose prefilled syringe is designed to deliver 200 mg of belimumab in 1 mL of solution and is supplied as follows: 200 mg/mL single-dose prefilled glass syringe with 27-gauge, half-inch needle attached in a carton of 4 (NDC 49401-088-47).
Requires Refrigeration